News

Podcast

The Growth of Telehealth During COVID-19 and Its Future After: Dr Patricia Salber Interviews Dr Joseph Kvedar

Telehealth has been around for years in the United States, but it was not until the coronavirus disease 2019 (COVID-19) pandemic that it became so widely used.

Telehealth has been around for years in the United States, but it was not until the coronavirus disease 2019 (COVID-19) pandemic that it became regularly used. The growth of telehealth was fueled by the inability to see patients in person at the beginning of the pandemic and a move by the government to temporarily relax regulations.

Joseph Kvedar, MD, president of the American Telemedicine Association, professor of Dermatology at Harvard Medical School, co-chair of the American Medical Association's Digital Medicine Payment Advisory Group, and editor-in-chief of npj Digital Medicine, explained that some of those relaxations might continue on after the COVID-19 pandemic passes, but some may get rolled back.

In conversation with Patricia Salber, MD, MBA, of The Doctor Weighs In, Kvedar also discussed how breakthroughs in technology have helped make virtual visits possible, the future of telehealth, and more.

Listen above or through one of these podcast services:

iTunes
TuneIn
Stitcher
Spotify

Learn more:

Contributor: Telehealth Claim Lines Increased 4132% Nationally From June 2019 to June 2020

Continuation of Routine Screenings, Care Is Crucial During COVID-19 Pandemic

ACR Position Statement Supports Use of Telemedicine After COVID-19 Crisis

Which Telehealth Changes Will Become Permanent? Hints May Come Next Month

In-person Visits Are Invaluable, but Telehealth Is Here to Stay​

Related Videos
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center (UPMC)
Pierluigi Porcu, MD
Image credit: Medical technology and futuristic concept. Doctor hologram modern virtual screen interface | SOMKID - stock.adobe.com
Erin Weber, MS
JC Scott, CEO and president of The Pharmaceutical Care Management Association (PCMA)
Elizabeth Grush, MBA
Cathy Eng, MD, FACP, FASCO, Vanderbilt-Ingram Cancer Center
Erin Weber, MS
Kenny Cole, MD
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo